Status:
COMPLETED
Comparison Suprascapular Nerve Block and Subacromial Injection in Hemiplegic Shoulder Pain
Lead Sponsor:
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Conditions:
Hemiplegia
Pain
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
Hemiplegic shoulder pain is the most common poststroke painful condition. Hemiplegic shoulder pain reduces range of motion (ROM) and hand function, resulting in limited daily life activity and decreas...
Detailed Description
Patients will be randomly assigned Subacromial injection group or Suprascapular nerve block group In the suprascapular nerve block group, suprascapular nerve block will be performed with a MyLab60 mo...
Eligibility Criteria
Inclusion
- Brunstrom stage 2 to 5
- spasticity \<4 according to the modified Ashworth scale
- having hemiplegia less than 12 months
- Presence of shoulder pain lasting more than 3 months
- Conservative treatment for painful shoulder before injection
Exclusion
- Patients over 75 years old, under 30 years old
- Anti-coagulant or antiaggregant use
- Presence of diabetes mellitus
- Patients who could not be cooperated and Mini-mental Test (MMSE) score \<24
- Having previously had suprascapular block or subacromial injection
- Presence of complex regional pain syndrome (type I),
- The presence of neglect syndrome
Key Trial Info
Start Date :
May 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04433377
Start Date
May 28 2020
End Date
October 1 2020
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
Istanbul, Bahcelievler, Turkey (Türkiye), 34180